Abiopharma

Clinical trial NCT05929664: status: RECRUITING → SUSPENDED.

Clinical trial NCT04262856: primary completion date: 2025-06-05 → 2025-07-09.

Clinical trial NCT07462910 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-02

Clinical trial NCT06015607 updates: 1. status: WITHHELD → RECRUITING 2. start date: not set → 2026-06-11 3. completion date: not set → 2027-08-01 4. primary completion date: not set → 2027-08-01 5. enrollment: not set → 30 participants 6. study type: not set → INTERVENTIONAL 7. enrollment type: not set …

Clinical trial NCT06110806 updates: 1. enrollment: 57 → 12 participants 2. collaborators added: National Center for Complementary and Integrative Health (NCCIH)

Clinical trial NCT05083403 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-11-01 → 2025-09-29 3. primary completion date: 2025-10-01 → 2024-05-14 4. enrollment: 350 → 170 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05257473 updates: 1. completion date: 2026-05-01 → 2026-08-01 2. primary completion date: 2026-05-01 → 2026-08-01

Clinical trial NCT04622046 updates: 1. collaborators added: Eidos Therapeutics, a BridgeBio company 2. collaborators removed: Eidos Therapeutics, a BridgeBio, Inc. Company

Clinical trial NCT07249320 updates: 1. enrollment: 39456 → 1 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07388498 updates: 1. completion date: 2028-07-18 → 2028-06-18 2. primary completion date: 2028-05-23 → 2028-06-18